Latest NewsJun 13, 2024EY Announces Liang Schweizer of HiFiBiO Therapeutics as an Entrepreneur Of The Year® 2024 New England Award WinnerAll Filter By: Year2024202320222021202020192018201720162015Sep 17, 2020HiFiBiO Therapeutics Presents Novel Approach to Patient Stratification Demonstrating DIS® Single-Cell Platform at 2020 AACR Tumor Heterogeneity ConferenceSep 3, 2020KITE AND HIFIBIO THERAPEUTICS PARTNER TO DISCOVER NOVEL TARGETS AND ANTIBODIES AGAINST ACUTE MYELOID LEUKEMIAAug 26, 2020HiFiBiO Therapeutics Submits IND Application for Fully Human SARS-CoV-2 Neutralizing Antibody for the Treatment of COVID-19 PatientsAug 17, 2020HiFiBiO Therapeutics Collaborates with Coronavirus Immunotherapy Consortium in the Fight Against COVID-19Jul 3, 2020HFB9-2, a novel Galectin-9 neutralizing antibody to reverse immune suppression in the tumor microenvironmentJul 3, 2020Discovery and characterization of novel TNFR2 antibodies to modulate T cell activities in immunosuppressive environment< 1 … 7 8 9 10 11 … 14 >